RE: RENX Renlytix plc/IB22 Aug 2025 09:52
So if semantic says “Frankly its very hard to imagine that insiders with very material involvement in the success or otherwise of the business, wouldn't have explored all the obvious options in great detail over the years” why were we told over a year ago that 40+ sales leads should lead to easy conversion to sales?
•All we are hearing at the moment is excuses for poor revenue.
•IB003 we seem to be exactly where we should have been a year ago judging by previous RNS’s re FDA meetings, phase 1 near completion, no commercial partners announced
•IB clinic nobody rushing to buy
•IB nimble we have not heard any more about the Blackford connection
•IB Neuro etc used everyday, so where is the revenue?
•GAM cancer user patent, no update on
•no update on GEHC revenue via sold in their pre loaded software package
We now how good our products are, if we can’t sell our products to customers maybe it’s time to sell our products to a buyer who could?
Sorry for appearing negative at the moment but we need more communication from the company, especially about what is going to change to increase revenue and IB003 funding. Silence leads to frustrations and rumblings amongst long term holders.
Have a good weekend everybody